ADARx Pharmaceuticals, Inc. (ADRX)
12.67
-1.49
(-10.52%)
USD |
NASDAQ |
Nov 20, 16:00
12.67
0.00 (0.00%)
After-Hours: 16:05
ADARx Pharmaceuticals Shareholders Equity (Quarterly) : 574.40M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 574.40M |
| June 30, 2026 | 106.57M |
| Date | Value |
|---|---|
| March 31, 2026 | 131.89M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 416.53M |
| IRulya Therapeutics, Inc. | 78.11M |
| PepGen Inc. | 103.07M |
| Q32 Bio, Inc. | 287.67M |
| Bridgebio Oncology Therapeutics, Inc. | 293.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 929.06M |
| Total Liabilities (Quarterly) | 354.66M |
| Debt to Equity Ratio | 0.0112 |
| Current Ratio | 21.08 |
| Net Debt Paydown Yield | -0.03% |